Drug is Available Worldwide and Inexpensive

There appears to be a significant breakthrough in the fight against COVID-19, and it comes in the form of a relatively inexpensive drug that has been available worldwide for years.

British scientists at Oxford University report Dexamethasone has reduced death rates by 35% for patients on ventilators and by 20% for those on oxygen.

Dexamethasone is a generic steroid that’s been used for 60 years to reduce inflammation in conditions such as arthritis and asthma. It is inexpensive, costing about one dollar per day in the U.S. and in many other parts of the world.

To date, it is the only drug that has shown to reduce mortality. However, the scientists noted that the drug does not appear to help patients with milder Coronavirus symptoms and who are not experiencing breathing problems.

Still, the findings represent a significant breakthrough in trial research. There has been a worldwide race to find a vaccine or cure for COVID-19, which has affected more than 8 million people and is responsible for more than 430,000 worldwide, as of this writing. Researchers remain hopeful about Remdesivir, an anti-viral drug created to fight Ebola, shown thus far, to reduce the duration of severe COVID-19 symptoms from 15 to 11 days.

Findings from the Oxford research study are in the process of being published.

Updates on this research will be published here.